[Ip-health] Statement by MSF on the conclusion of TPP negotiations

Joanna Keenan joanna.l.keenan at gmail.com
Tue Oct 6 03:03:38 PDT 2015

Statement by Doctors Without Borders/ Médecins Sans Frontières (MSF) on the
conclusion of TPP negotiations in Atlanta


"MSF expresses its dismay that TPP countries have agreed to United States
government and multinational drug company demands that will raise the price
of medicines for millions by unnecessarily extending monopolies and further
delaying price-lowering generic competition. The big losers in the TPP are
patients and treatment providers in developing countries.  Although the
text has improved over the initial demands, the TPP will still go down in
history as the worst trade agreement for access to medicines in developing
countries, which will be forced to change their laws to incorporate abusive
intellectual property protections for pharmaceutical companies. For
example, the additional monopoly protection provided for biologic drugs
will be a new regime for all TPP developing countries.  These countries
will pay a heavy price in the decades to come that will be measured in the
impact it has on patients.  As the trade agreement now goes back to the
national level for countries's final approval, we urge all governments to
carefully consider before they sign on the dotted line whether this is the
direction they want to take on access to affordable medicines and the
promotion of biomedical innovation. The negative impact of the TPP on
public health will be enormous, be felt for years to come and it will not
be limited to the current 12 TPP countries, as it is a dangerous blueprint
for future agreements."

- Judit Rius Sanjuan, US Manager & Legal Policy Adviser, MSF Access

Kind regards


Joanna Keenan
Press Officer
Médecins Sans Frontières - Access Campaign
P: +41 22 849 87 45
M: +41 79 203 13 02
E: joanna.keenan[at]geneva.msf.org
T: @joanna_keenan


More information about the Ip-health mailing list